Cadila 
Welcome,         Profile    Billing    Logout  
 6 Products   53 Diseases  6 Products   4 Trials   59 News 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ritucad (rituximab biosimilar) / Cadila
rituximabNovCad: A randomized controlled study to evaluate pharmacokinetic, pharmacodynamic (efficacy) and safety of Rituximab (Zydus) and Rituximab (Roche) in patients with Rheumatoid Arthritis

Recruiting
1
24
RoW
Cadila Healthcare Limited
Rheumatoid Arthritis
 
 
rituximabZydCad1: A randomized controlled study to evaluate pharmacokinetic, pharmacodynamic (efficacy) and safety of Rituximab (Zydus) and Rituximab (Roche) in patients with Rheumatoid Arthritis

Recruiting
1
24
India
rituximab biosimilar
Cadila
Rheumatoid arthritis
 
 
EPEG (pegylated recombinant erythropoietin) / Cadila, Prolong Pharma
ACTRN12613000374763: A Phase 1 Single Blind, Randomized, Single-Dose, Safety, Tolerability, Pharmacodynamic, and Pharmacokinetic Study of ZY7318 (pegylated recombinant human erythropoietin) in Healthy Volunteers

Recruiting
1
32
 
Prolong Pharmaceuticals, LLC, Prolong Pharmaceuticals, LLC
Healthy volunteers study and investigational product would be targeted for secondary anemia due to renal cause.
 
 
Cadalimab (adalimumab biosimilar) / Cadila
adalimumabZydCad: A study to evaluate efficacy, tolerability and safety of Adalimumab (Zydus) and Adalimumab (Reference) in patients with Rheumatoid Arthritis

Not yet recruiting
3
120
RoW
adalimumab biosimilar
Cadila Healthcare Limited
 
 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ritucad (rituximab biosimilar) / Cadila
rituximabNovCad: A randomized controlled study to evaluate pharmacokinetic, pharmacodynamic (efficacy) and safety of Rituximab (Zydus) and Rituximab (Roche) in patients with Rheumatoid Arthritis

Recruiting
1
24
RoW
Cadila Healthcare Limited
Rheumatoid Arthritis
 
 
rituximabZydCad1: A randomized controlled study to evaluate pharmacokinetic, pharmacodynamic (efficacy) and safety of Rituximab (Zydus) and Rituximab (Roche) in patients with Rheumatoid Arthritis

Recruiting
1
24
India
rituximab biosimilar
Cadila
Rheumatoid arthritis
 
 
EPEG (pegylated recombinant erythropoietin) / Cadila, Prolong Pharma
ACTRN12613000374763: A Phase 1 Single Blind, Randomized, Single-Dose, Safety, Tolerability, Pharmacodynamic, and Pharmacokinetic Study of ZY7318 (pegylated recombinant human erythropoietin) in Healthy Volunteers

Recruiting
1
32
 
Prolong Pharmaceuticals, LLC, Prolong Pharmaceuticals, LLC
Healthy volunteers study and investigational product would be targeted for secondary anemia due to renal cause.
 
 
Cadalimab (adalimumab biosimilar) / Cadila
adalimumabZydCad: A study to evaluate efficacy, tolerability and safety of Adalimumab (Zydus) and Adalimumab (Reference) in patients with Rheumatoid Arthritis

Not yet recruiting
3
120
RoW
adalimumab biosimilar
Cadila Healthcare Limited
 
 

Download Options